{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:17:20Z","timestamp":1789906640049,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jns.2021.117549","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:33:13Z","timestamp":1624062793000},"page":"117549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy"],"prefix":"10.1016","volume":"427","author":[{"given":"Sini M.","family":"Laakso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Myllynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Strbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Atula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2021.117549_bb0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front. Immunol"},{"key":"10.1016\/j.jns.2021.117549_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","article-title":"Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review","volume":"52","author":"Truffault","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jns.2021.117549_bb0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: immunological and clinical aspects","volume":"10","author":"Skeie","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3389\/fneur.2020.00981","article-title":"From traditional to targeted immunotherapy in myasthenia gravis: prospects for research","volume":"11","author":"Mantegazza","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jtcvs.2016.01.006","article-title":"Evidence for thymectomy in myasthenia gravis: getting stronger?","volume":"154","author":"de Perrot","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jns.2021.117549_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1474-4422(18)30467-8","article-title":"Thymectomy in myasthenia gravis: when, why, and how?","volume":"18","author":"Berrih-Aknin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized Trial of Thymectomy in Myasthenia Gravis [published correction appears in N Engl J Med. 2017;376(21):2097. [Dosage error in article text]]","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jns.2021.117549_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.0b013e31827b907b","article-title":"Complete stable remission and autoantibody specificity in myasthenia gravis","volume":"80","author":"Baggi","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.117549_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419832242","article-title":"Understanding the burden of refractory myasthenia gravis","volume":"12","author":"Schneider-Gold","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2021.117549_bb0055","first-page":"255","article-title":"Clinical characteristics of refractory myasthenia gravis patients","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jns.2021.117549_bb0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00415-019-09667-5","article-title":"Frequency and clinical features of treatment-refractory myasthenia gravis","volume":"267","author":"Rath","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2021.117549_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur. J. Neurol"},{"key":"10.1016\/j.jns.2021.117549_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/ane.13254","article-title":"Prevalence and risk of thyroid diseases in myasthenia gravis","volume":"142","author":"Chou","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2021.117549_bb0080","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jns.2021.117549_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jns.2021.117549_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.537","article-title":"Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course","volume":"6","author":"Kubiszewska","year":"2016","journal-title":"Brain Behav."},{"key":"10.1016\/j.jns.2021.117549_bb0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/acn3.51055","article-title":"Risk of incident autoimmune diseases in patients with thymectomy","volume":"7","author":"Lin","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2021.117549_bb0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol. Belg"},{"key":"10.1016\/j.jns.2021.117549_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12883-017-0857-7","article-title":"Clinical predictors for the prognosis of myasthenia gravis","volume":"17","author":"Wang","year":"2017","journal-title":"B.M.C. Neurol"},{"key":"10.1016\/j.jns.2021.117549_bb0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2004.00968.x","article-title":"Associated conditions in myasthenia gravis: response to thymectomy","volume":"11","author":"T\u00e9llez-Zenteno","year":"2004","journal-title":"Eur. J. Neurol"},{"key":"10.1016\/j.jns.2021.117549_bb0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/icvts\/ivaa021","article-title":"Improvement in symptom remission rate following robotic thymectomy in patients with myasthenia gravis","volume":"30","author":"Kauppi","year":"2020","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.jns.2021.117549_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards, task force of the medical scientific advisory board of the myasthenia gravis foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg"},{"key":"10.1016\/j.jns.2021.117549_bb0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2021.117549_bb0130","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MLR.0b013e318297429c","article-title":"Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work","volume":"53","author":"Austin","year":"2015","journal-title":"Med. Care"},{"key":"10.1016\/j.jns.2021.117549_bb0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jns.2021.117549_bb0140","doi-asserted-by":"crossref","first-page":"116520","DOI":"10.1016\/j.jns.2019.116520","article-title":"Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: a retrospective national registry study","volume":"407","author":"Sipil\u00e4","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2021.117549_bb0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:17Z","timestamp":1758383897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":29,"alternative-id":["S0022510X21002434"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.117549","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.117549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117549"}}